Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Biogen Inc. (BIIB) stock news and headlines to help you in your trading and investing decisions.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Jan 27, 2025 · Biogen BIIB announced that the FDA has approved a monthly maintenance dosing version for its intravenously (IV) administered Alzheimer's disease (AD) drug, Leqembi.

Biogen (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

See the company profile for Biogen Inc. (BIIB) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Discover historical prices for BIIB stock on Yahoo Finance. View daily, weekly or monthly format back to when Biogen Inc. stock was issued.

Feb 2, 2025 · In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other S&P 500 stocks.

Biogen Inc (NASDAQ:BIIB) reported a 66% growth in global revenue for LEQEMBI in the third quarter compared to the second quarter, with significant uptake outside the US, particularly in Japan.

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a ...